tetano
Editor, Senior Moderator
Cells
. 2026 Jan 26;15(3):234.
doi: 10.3390/cells15030234.
Cellular and Molecular Mechanisms of SARS-CoV-2 Spike Protein-Induced Endothelial Dysfunction
Kelsey C Muir[SUP] 1 2 [/SUP], Dwight D Harris[SUP] 2 [/SUP], Meghamsh Kanuparthy[SUP] 1 2 [/SUP], Jiayu Hu[SUP] 2 [/SUP], Ju-Woo Nho[SUP] 2 [/SUP], Christopher Stone[SUP] 1 2 [/SUP], Debolina Banerjee[SUP] 1 [/SUP], Frank W Sellke[SUP] 1 2 [/SUP], Jun Feng[SUP] 3 [/SUP]
Affiliations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is initiated by the viral spike proteins, which are key structural components that mediate host cell binding and entry and alter downstream signaling through multiple interactions with endothelial surface receptors. Endothelial dysfunction is a central consequence of COVID-19, contributing to vascular inflammation, barrier disruption, thrombosis, and multi-organ injury affecting the pulmonary, cardiovascular, cerebral, and renal systems. Emerging evidence demonstrates that spike protein-mediated effects, independent of productive viral infection, disrupt endothelial homeostasis through angiotensin-converting enzyme 2 (ACE2) dysregulation, integrin engagement, altered calcium signaling, junctional protein remodeling, oxidative stress, and pro-inflammatory and pro-apoptotic pathways. This review is intentionally focused on spike (S) protein-driven mechanisms of endothelial dysfunction; pathogenic vascular effects attributed to other SARS-CoV-2 structural proteins, including the nucleocapsid (N) protein, are beyond the scope of this discussion. In this review, we synthesize current experimental and translational data detailing the molecular mechanisms by which the SARS-CoV-2 spike protein drives endothelial dysfunction across multiple organ systems and discuss potential therapeutic strategies aimed at preserving endothelial integrity in acute COVID-19 and its long-term vascular sequela.
Keywords: COVID-19; SARS-CoV-2; endothelial dysfunction; endothelial permeability; spike protein.
. 2026 Jan 26;15(3):234.
doi: 10.3390/cells15030234.
Cellular and Molecular Mechanisms of SARS-CoV-2 Spike Protein-Induced Endothelial Dysfunction
Kelsey C Muir[SUP] 1 2 [/SUP], Dwight D Harris[SUP] 2 [/SUP], Meghamsh Kanuparthy[SUP] 1 2 [/SUP], Jiayu Hu[SUP] 2 [/SUP], Ju-Woo Nho[SUP] 2 [/SUP], Christopher Stone[SUP] 1 2 [/SUP], Debolina Banerjee[SUP] 1 [/SUP], Frank W Sellke[SUP] 1 2 [/SUP], Jun Feng[SUP] 3 [/SUP]
Affiliations
- PMID: 41677601
- DOI: 10.3390/cells15030234
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is initiated by the viral spike proteins, which are key structural components that mediate host cell binding and entry and alter downstream signaling through multiple interactions with endothelial surface receptors. Endothelial dysfunction is a central consequence of COVID-19, contributing to vascular inflammation, barrier disruption, thrombosis, and multi-organ injury affecting the pulmonary, cardiovascular, cerebral, and renal systems. Emerging evidence demonstrates that spike protein-mediated effects, independent of productive viral infection, disrupt endothelial homeostasis through angiotensin-converting enzyme 2 (ACE2) dysregulation, integrin engagement, altered calcium signaling, junctional protein remodeling, oxidative stress, and pro-inflammatory and pro-apoptotic pathways. This review is intentionally focused on spike (S) protein-driven mechanisms of endothelial dysfunction; pathogenic vascular effects attributed to other SARS-CoV-2 structural proteins, including the nucleocapsid (N) protein, are beyond the scope of this discussion. In this review, we synthesize current experimental and translational data detailing the molecular mechanisms by which the SARS-CoV-2 spike protein drives endothelial dysfunction across multiple organ systems and discuss potential therapeutic strategies aimed at preserving endothelial integrity in acute COVID-19 and its long-term vascular sequela.
Keywords: COVID-19; SARS-CoV-2; endothelial dysfunction; endothelial permeability; spike protein.